Hypothyroidism can push your body toward insulin resistance and higher blood sugar, creating conditions that look like prediabetes on lab work. But there’s an important wrinkle: low thyroid hormone also inflates HbA1c readings independently of your actual blood sugar, which means some people with hypothyroidism get labeled as prediabetic when they aren’t. One study found that 20% of non-diabetic patients with overt hypothyroidism were misclassified as having prediabetes based on HbA1c alone. So the connection is real, but it’s also more complicated than a simple yes or no.
How Low Thyroid Hormone Disrupts Blood Sugar
Thyroid hormone acts on your liver, muscles, pancreas, and fat tissue to regulate how your body processes glucose. When thyroid levels drop, several things go wrong at once. In the liver, low thyroid hormone triggers a stress response inside cells that interferes with insulin signaling. Essentially, the stress pathway activates a chain reaction that blocks insulin from doing its job, making liver cells less responsive to the hormone that normally keeps blood sugar in check.
Your skeletal muscles are the biggest consumers of glucose in your body, and they depend on thyroid hormone to efficiently pull sugar out of your bloodstream. When thyroid function is low, that uptake slows down. The result is glucose lingering in your blood longer than it should, which is the core problem behind both insulin resistance and prediabetes.
Altered thyroid levels also shift your lipid profile in ways that compound the problem. People with even subclinical hypothyroidism (where TSH is elevated but thyroid hormones are still technically in range) show significantly higher total cholesterol and LDL cholesterol. Elevated lipids contribute to metabolic dysfunction and make insulin resistance worse over time. Triglycerides and fasting insulin levels tend to run higher too, though the differences are more modest.
What the Numbers Say About Risk
A pooled analysis of studies tracking people over time found that hypothyroidism raises the risk of developing type 2 diabetes by about 26%. That’s a meaningful increase, though not dramatic. The data on prediabetes specifically is thinner. One large study found that people with hypothyroidism had a higher risk of prediabetes but, interestingly, not of type 2 diabetes itself. That suggests hypothyroidism may be especially relevant in the early, reversible stages of blood sugar dysfunction.
Even TSH levels in the high-normal range (2.5 to 4.5 mU/L, well within what most labs call “normal”) appear to matter. In people with type 2 diabetes, those with TSH in the upper half of normal had higher BMI, higher blood pressure, higher triglycerides, and worse blood sugar control. When TSH sat in the lower-normal range, the percentage of patients missing their blood sugar targets dropped from 27.5% to 12.5%. This hints that thyroid function doesn’t need to be overtly abnormal to influence glucose metabolism.
The HbA1c Problem You Should Know About
This is the part that catches many people off guard. HbA1c, the standard test used to diagnose prediabetes, measures how much sugar has attached to your red blood cells over the past two to three months. But hypothyroidism slows the turnover of red blood cells, meaning each cell circulates longer and accumulates more sugar on its surface. The result is an HbA1c reading that looks elevated even when your day-to-day blood sugar is normal.
A study of 30 non-diabetic patients with overt hypothyroidism illustrates this clearly. During their hypothyroid state, 10 of them (33%) had an HbA1c of 5.7% or higher, the threshold for a prediabetes diagnosis. After thyroid hormone replacement brought their levels back to normal, only 4 (13%) still met that cutoff. Six patients, a full 20% of the group, had been misclassified as prediabetic entirely because of their thyroid condition. Their fasting blood glucose never actually changed.
If you’ve been told you have prediabetes and you also have untreated or undertreated hypothyroidism, this is worth discussing with your provider. A fasting glucose test or a different marker may give a more accurate picture of your actual blood sugar status.
Subclinical Hypothyroidism and Metabolic Risk
You don’t need full-blown hypothyroidism for metabolic effects to show up. Subclinical hypothyroidism, where TSH is elevated but free thyroid hormones remain in the normal range, is far more common and affects roughly 4 to 10% of adults. Research shows it’s associated with elevated cholesterol and a trend toward higher insulin resistance, even if those changes don’t always reach statistical significance in smaller studies.
There’s also a bidirectional relationship at play. Metabolic syndrome (the cluster of high blood sugar, high blood pressure, excess abdominal fat, and abnormal lipids) more than doubles the odds of developing subclinical hypothyroidism, with a pooled odds ratio of 2.56. So the two conditions feed each other: thyroid dysfunction worsens metabolic health, and poor metabolic health makes thyroid problems more likely.
The Autoimmune Overlap
Most hypothyroidism in developed countries is caused by Hashimoto’s thyroiditis, an autoimmune condition. People with one autoimmune disease are more prone to developing others. Among patients with type 1 diabetes (which is autoimmune and destroys insulin-producing cells), 15 to 30% also have autoimmune thyroid disease. This isn’t directly relevant to prediabetes, which is a different pathway than type 1 diabetes. But if you have Hashimoto’s, your immune system is already primed for autoimmune activity, and that broader inflammatory environment can contribute to insulin resistance on its own.
Does Treating Hypothyroidism Fix the Problem?
Thyroid hormone replacement clearly improves some metabolic markers. In a study of 105 patients with untreated hypothyroidism, three months of treatment significantly reduced BMI, total cholesterol, LDL cholesterol, triglycerides, and fasting insulin levels. Cholesterol dropped from an average of about 200 to 178 mg/dL. Those are meaningful improvements.
The picture for insulin resistance itself is less clear-cut. Standard measures of insulin resistance (HOMA-IR and QUICKI) didn’t significantly improve after treatment in multiple studies. However, when researchers used more sensitive testing methods like the glucose clamp technique, they did find reductions in insulin resistance. The discrepancy likely means that thyroid replacement helps, but the improvement may be subtle enough that routine blood tests don’t always capture it.
What treatment does reliably fix is the false HbA1c elevation. If your “prediabetes” was partly or entirely an artifact of slow red blood cell turnover, getting your thyroid levels normalized should bring your HbA1c back to a number that actually reflects your blood sugar. For some people, that alone may resolve a prediabetes diagnosis. For others whose insulin resistance is real, thyroid treatment is one piece of the puzzle alongside the usual strategies of physical activity, dietary changes, and weight management.